Logo image of APYX

APYX MEDICAL CORP (APYX) Stock Price, Quote, News and Overview

NASDAQ:APYX - Nasdaq - US03837C1062 - Common Stock - Currency: USD

1.51  +0.06 (+3.82%)

APYX Quote, Performance and Key Statistics

APYX MEDICAL CORP

NASDAQ:APYX (2/21/2025, 8:01:32 PM)

1.51

+0.06 (+3.82%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High2.3
52 Week Low0.97
Market Cap61.28M
Shares40.58M
Float34.97M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-13 2025-03-13/amc
IPO07-22 1983-07-22


APYX short term performance overview.The bars show the price performance of APYX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

APYX long term performance overview.The bars show the price performance of APYX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of APYX is 1.51 USD. In the past month the price decreased by -1.31%. In the past year, price decreased by -24.88%.

APYX MEDICAL CORP / APYX Daily stock chart

APYX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.89 234.01B
ISRG INTUITIVE SURGICAL INC 80.74 211.07B
BSX BOSTON SCIENTIFIC CORP 41.63 154.00B
SYK STRYKER CORP 31.4 145.92B
MDT MEDTRONIC PLC 16.84 115.33B
BDX BECTON DICKINSON AND CO 16.35 65.30B
EW EDWARDS LIFESCIENCES CORP 27.98 43.23B
GEHC GE HEALTHCARE TECHNOLOGY 20.29 41.62B
IDXX IDEXX LABORATORIES INC 40.25 37.07B
DXCM DEXCOM INC 53.81 34.68B
RMD RESMED INC 26.21 34.03B
PHG KONINKLIJKE PHILIPS NVR- NY 17.5 24.02B

About APYX

Company Profile

APYX logo image Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 252 full-time employees. The firm's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.

Company Info

APYX MEDICAL CORP

5115 Ulmerton Rd

Clearwater FLORIDA 33760 US

CEO: Charles D. Goodwin II

Employees: 252

Company Website: https://apyxmedical.com/

Investor Relations: https://apyxmedical.com/investor_relations/

Phone: 18005372790

APYX MEDICAL CORP / APYX FAQ

What is the stock price of APYX MEDICAL CORP today?

The current stock price of APYX is 1.51 USD. The price increased by 3.82% in the last trading session.


What is the ticker symbol for APYX MEDICAL CORP stock?

The exchange symbol of APYX MEDICAL CORP is APYX and it is listed on the Nasdaq exchange.


On which exchange is APYX stock listed?

APYX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for APYX MEDICAL CORP stock?

10 analysts have analysed APYX and the average price target is 3.06 USD. This implies a price increase of 102.65% is expected in the next year compared to the current price of 1.51. Check the APYX MEDICAL CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is APYX MEDICAL CORP worth?

APYX MEDICAL CORP (APYX) has a market capitalization of 61.28M USD. This makes APYX a Micro Cap stock.


How many employees does APYX MEDICAL CORP have?

APYX MEDICAL CORP (APYX) currently has 252 employees.


What are the support and resistance levels for APYX MEDICAL CORP (APYX) stock?

APYX MEDICAL CORP (APYX) has a support level at 1.38 and a resistance level at 1.51. Check the full technical report for a detailed analysis of APYX support and resistance levels.


Is APYX MEDICAL CORP (APYX) expected to grow?

The Revenue of APYX MEDICAL CORP (APYX) is expected to decline by -9.98% in the next year. Check the estimates tab for more information on the APYX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy APYX MEDICAL CORP (APYX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does APYX MEDICAL CORP (APYX) stock pay dividends?

APYX does not pay a dividend.


When does APYX MEDICAL CORP (APYX) report earnings?

APYX MEDICAL CORP (APYX) will report earnings on 2025-03-13, after the market close.


What is the Price/Earnings (PE) ratio of APYX MEDICAL CORP (APYX)?

APYX MEDICAL CORP (APYX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.83).


What is the Short Interest ratio of APYX MEDICAL CORP (APYX) stock?

The outstanding short interest for APYX MEDICAL CORP (APYX) is 0.43% of its float. Check the ownership tab for more information on the APYX short interest.


APYX Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to APYX. When comparing the yearly performance of all stocks, APYX is a bad performer in the overall market: 77.26% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

APYX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to APYX. APYX may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

APYX Financial Highlights

Over the last trailing twelve months APYX reported a non-GAAP Earnings per Share(EPS) of -0.83. The EPS decreased by -62.75% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -46.84%
ROE -257.6%
Debt/Equity 3.07
Chartmill High Growth Momentum
EPS Q2Q%-7.69%
Sales Q2Q%-4.08%
EPS 1Y (TTM)-62.75%
Revenue 1Y (TTM)-3.5%

APYX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 76% to APYX. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of -15.98% and a revenue growth -9.98% for APYX


Ownership
Inst Owners41.63%
Ins Owners13.56%
Short Float %0.43%
Short Ratio3.5
Analysts
Analysts76
Price Target3.06 (102.65%)
EPS Next Y-15.98%
Revenue Next Year-9.98%